Cleamix Oy
Cleamix Ltd. is a Finnish technology company specializing in advanced hydrogen peroxide vapor (vH₂O₂) decontamination solutions. Originally co-developed with the Finnish Defence Forces and the VTT Technical Research Centre of Finland, our patented technology is now utilized across healthcare, pharmaceuticals, food production, and defense sectors. Our mobile, scalable devices provide rapid, automated, and residue-free eradication of bacteria, viruses, and spores, achieving a guaranteed 6-log microbial reduction. We are dedicated to delivering reliable, environmentally safe decontamination to ensure the highest hygiene standards, strict regulatory compliance, and occupational safety worldwide, protecting both patients and professionals from harmful contaminants.
Approach to Healthcare
Cleamix’s philosophy centers on preventative safety, uncompromising efficacy, and minimal disruption. Our approach to healthcare is to provide hospitals, clinics, and laboratories with a non-toxic, highly reliable method to eliminate healthcare-associated infections (HAIs). By utilizing automated vaporized hydrogen peroxide that naturally decomposes into safe water vapor and oxygen, we minimize human error and eliminate hazardous chemical exposure for hospital staff. We contribute to the improvement of healthcare services by drastically reducing facility downtime during the deep decontamination of ICUs, operating rooms, and emergency vehicles, thereby protecting vulnerable patients without risking damage to sensitive medical electronics.
Impact of Product/Services on Healthcare
Our vH₂O₂ decontamination systems directly address the critical problem of antibiotic-resistant bacteria and viral outbreaks in clinical settings. Traditional manual disinfection is time-consuming, prone to human error, and often leaves toxic chemical residues. Cleamix solves this by providing precise, repeatable, and residue-free sterilization that permeates even the hardest-to-reach micro-crevices. By guaranteeing a 6-log reduction in microbial contaminants, our portable units actively stop the spread of infections, prevent costly ward shutdowns, and ensure that healthcare facilities effortlessly meet the strictest regulatory hygiene and patient safety standards.
Innovation
The core innovation of Cleamix lies in our proprietary vH₂O₂ generation method, which achieves highly efficient vaporization and yields significantly more gas per volume than conventional systems. Our software uses state-of-the-art sensors for real-time monitoring of temperature, humidity, and H₂O₂ concentration (ppm), adjusting the output on the fly to prevent condensation and saturation. This ensures absolute material compatibility for sensitive hospital equipment, while remote Wi-Fi monitoring and automated data logging provide seamless traceability for compliance reporting.
Future Direction
Moving forward, Cleamix aims to deepen our integration within global healthcare infrastructure. We are expanding our networked, modular solutions (such as our master and extension units), allowing hospitals to simultaneously decontaminate multiple rooms, massive volumes, or isolated “decontamination bubbles” from a single remote location. We are also advancing customized, permanent integrations of our VHP technology directly into facility enclosures, mobile medical units, and cell culture suites. Our ultimate goal is to make industrial-grade, automated 6-log sterilization an accessible, standard daily practice in medical environments, proactively enhancing global public health readiness against emerging biological threats.